Abstract
Objectives
Radiotherapy is currently used in patients with residual or recurrent pituitary adenomas after surgery. However, there is little information of long-term outcome of patients with Cushing’s disease following radiotherapy. We assessed the long-term efficacy and toxicity of conventional radiotherapy in the control of Cushing’s disease after unsuccessful transsphenoidal surgery.
Patients and Methods
Forty patients with Cushing’s disease were treated with conventional external beam radiotherapy at our Institution between 1988 and 2002. The median age was 38. All patients received radiotherapy following unsuccessful surgery or at tumour recurrence to a dose of 45–50 Gy in 25–28 fractions. The persistence of active disease after surgery was diagnosed by the increased high plasma cortisol levels, high 24 h urinary cortisol levels and absence of cortisol suppression after administration of dexamethasone.
Results
The 5 and 10 year local tumour control was 93% and the 5 and 10 year survival was 97 and 95%. Normalization of plasma cortisol was seen in 28% of patients at 1 year, 73% at 3 years, 78% at 5 years and 84% at 10 years. The average timing to remission was 24 months. The most common side effect was hypopituitarism that increased progressively during the follow-up, being present in 62% and in 76% of patients at 5 and 10 years after RT. There were no other serious complications as radiation induced optic neuropathy or second tumours.
Conclusion
Radiotherapy is effective in the long-term tumour- and hormone hypersecretion control of ACTH-secreting pituitary adenomas, however with a high prevalence of hypopituitarism. At the moment, it remains an important treatment option after failure of surgery.
Similar content being viewed by others
References
Orth DN (1995) Cushing’s syndrome. N Engl J Med 332:791–803
Mampalam TJ, Tyrrel JB, Wilson CB (1988) Transsphenoidal microsurgery for Cushing’s disease: a report of 216 cases. Ann Inter Med 109:487–493
Bochicchio D, Losa M, Buchfelder M, for the European Survey Study Group (1995) Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab 80:3114–3120
Blevins LS, Christy JH, Khajavi M, Tindall GT (1998) Outcomes of therapy for Cushing’s disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 83:63–67
Shimon I, Ram Z, Cohen ZR, Hadani M (2002) Transsphenoidal surgery for Cushing’s disease: endocrinological follow-up monitoring 82 patients. Neurosurgery 51:57–61
Hammer GD, Tyrrell JB, Lamborn KR et al (2004) Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results. J Clin Endocrinol Metab 89:6348–6357
Brada M, Rajan B, Traish D et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38:571–578
Tsang RW, Brierly JD, Panzarella T et al (1994) Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30:557–565
Zierhut D, Flentje M, Adolph J et al (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314
Rush S, Cooper PR (1997) Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phys 37:1031–1034
Barrande G, Pittino-Lungo M, Coste J et al (2000) Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85:3779–3785
Isobe K, Ohta M, Yasuda’ S et al (2000) Postoperative radiation therapy for pituitary adenoma. J Neurooncol 48:135–140
Kokubo M, Sasai K, Shibamoto Y et al (2000) Long-term results of radiation therapy for pituitary adenoma. J Neurooncol 47:79–84
Minniti G, Jaffrain-Rea ML, Osti M et al (2005) The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 62:210–216
Sharpe GF, Kendall-Taylor P, Prescott RW et al (1985) Pituitary function following megavoltage therapy for Cushing’s disease: long term follow up. Clin Endocrinol (Oxf) 22:169–177
Howlett TA, Plowman PN, Wass JA et al (1989) Megavoltage pituitary irradiation in the management of Cushing’s disease and Nelson’s syndrome: long-term follow-up. Clin Endocrinol (Oxf) 31:309–323
Murayama M, Yasuda K, Minamori Y et al (1992) Long term follow-up of Cushing’s disease treated with reserpine and pituitary irradiation. J Clin Endocrinol Metab 75:935–942
Estrada J, Boronat M, Mielgo M et al (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 336:172–177
Arnaldi G, Angeli A, Atkinson Abet al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602
Storr HL, Plowman PN, Carroll PV et al (2003) Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing’s disease: an effective second-line treatment. J Clin Endocrinol Metab 88:34–37
Brada M, Ajithkumary TV, Minniti G (2004) Radiosurgery for pituitary adenomas. Clin Endocrinol (Oxf) 61:531–543
Sheehan JM, Vance ML, Sheehan JP et al (2000) Radiosurgery for Cushing’s disease after failed transsphenoidal surgery. J Neurosurg 93:738–742
Hoybye C, Grenback E, Rahn T et al (2001) Adrenocorticotropic hormone-producing pituitary tumours: 12 to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49:284–291: discussion 291–282
Degerblad M, Rahn T, Bergstrand G, Thoren M. (1986) Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing’s disease. Acta Endocrinol (Copenh) 112:310–314
Kobayashi T, Kida Y, Mori Y (2002) Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. J Neurosurg 97(5):422–428
Littley MD, Shalet SM, Beardwell CG et al (1990) Long-term follow-up of low-dose external pituitary irradiation for Cushing’s disease. Clin Endocrinol (Oxf) 33:445–455
Brada M, Ashley S, Ford D et al (2002) Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol (Oxf) 57:713–717
Erfurth EM, Bulow B, Svahn-Tapper G et al (2002). Risk factors for cerebrovascular deaths in patients operated and irradiatied for pituitary tumours. J Clin Endocrinol Metab 87:4892–4899
Minniti G, Traish D, Ashley S et al (2005) Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90:800–804
Acknowledgements
This study was supported by the Radiotherapy Oncology Research Fund of University of Rome “La Sapienza”.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Minniti, G., Osti, M., Jaffrain-Rea, M.L. et al. Long-term follow-up results of postoperative radiation therapy for Cushing’s disease. J Neurooncol 84, 79–84 (2007). https://doi.org/10.1007/s11060-007-9344-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9344-0